Literature DB >> 20638020

Natural history of chronic hepatitis B.

Brian J McMahon1.   

Abstract

In this article, the 4 phases of chronic HBV infection are reviewed and the factors that are associated with disease progression and the development of hepatocellular carcinoma (HCC) and cirrhosis are discussed. Also discussed is what is known to date about how to identify persons at the highest risk of developing HCC and/or cirrhosis. Finally, ways in which the natural history can be altered by hepatitis B vaccination and identification, close monitoring, and appropriate treatment of chronically infected individuals are reviewed. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20638020     DOI： 10.1016/j.cld.2010.05.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  53 in total

1.  Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.

Authors:  Jin-Lin Cheng; Hong Zhao; Shi-Gui Yang; Er-Mei Chen; Wen-Qian Chen; Lan-Juan Li
Journal:  Hepatol Int       Date:  2018-06-07       Impact factor: 6.047

2.  Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics.

Authors:  Kevin C Ku; Jiayi Li; Nghi B Ha; Marina Martin; Vincent G Nguyen; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

Review 3.  Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors:  Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal:  World J Hepatol       Date:  2015-03-27

4.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

6.  Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response.

Authors:  Gu-Choul Shin; Hong Seok Kang; Ah Ram Lee; Kyun-Hwan Kim
Journal:  Autophagy       Date:  2016-10-14       Impact factor: 16.016

Review 7.  Aging and liver disease.

Authors:  In Hee Kim; Tatiana Kisseleva; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

Review 8.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

9.  Eradication of hepatitis B: a nationwide community coalition approach to improving vaccination, screening, and linkage to care.

Authors:  Chari Cohen; Jeffrey Caballero; Melinda Martin; Isha Weerasinghe; Michelle Ninde; Joan Block
Journal:  J Community Health       Date:  2013-10

10.  Association of chronic viral hepatitis B with insulin resistance.

Authors:  Jeong Gyu Lee; Sangyeoup Lee; Yun Jin Kim; Byung Mann Cho; Joo Sung Park; Hyung Hoi Kim; Jaehun Cheong; Dong Wook Jeong; Yu Hyun Lee; Young Hye Cho; Mi Jin Bae; Eun Jung Choi
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.